Charles Schwab Investment Management Inc Clear Point Neuro, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 10,369 shares of CLPT stock, worth $173,369. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,369
Previous 10,369
-0.0%
Holding current value
$173,369
Previous $116,000
37.07%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CLPT
# of Institutions
93Shares Held
7.57MCall Options Held
390KPut Options Held
28.7K-
Vanguard Group Inc Valley Forge, PA1.25MShares$20.9 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA509KShares$8.51 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA409KShares$6.84 Million1.22% of portfolio
-
Black Rock Inc. New York, NY366KShares$6.13 Million0.0% of portfolio
-
Brown Advisory Inc333KShares$5.57 Million0.01% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $409M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...